Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Tiny trial tests artificial vein valve for leg swelling

NCT ID NCT05883943

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early study tests a new device called the Cook® Venous Valve System in just 4 people with chronic venous insufficiency (leg veins that don't pump blood back to the heart properly). The valve is implanted through a small tube into a deep leg vein to help blood flow one way. The main goal is to check safety in the first 30 days, with follow-ups up to a year.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Cook® Venous Valve System (a permanent prosthetic valve implanted in the leg vein)
What this could lead to
If it works, this could offer a new treatment option for chronic venous insufficiency, potentially reducing leg swelling and pain.
What could go wrong
This is a very early, tiny study with only 4 people. The device may not work as hoped, and risks include blood clots, bleeding, or device movement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

4 people

The number who actually took part.

Started

Apr 2023

Expected to finish

Sep 2028

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Limited inclusion criteria: * Documented symptomatic deep venous reflux in one limb * Deep venous reflux in the region of interest Limited exclusion criteria: General: * Age \< 18 years * BMI ≥ 40 * Cultural objections to porcine materials * Unwillingness or inability to comply with the follow-up * Unwillingness to provide study data for duration of study * Simultaneous participation in another device or drug study * Inability or refusal to give informed consent Medical: * Pregnant, or planning to become pregnant * Diagnosis of terminal illness with life expectancy less than 12 months * Complete symptom resolution with compliant compression therapy for three months * Untreated superficial venous disease * Medical interventions including any of the following: planned procedure of any leg, vascular intervention or major surgery within the last three months, implanted inferior vena cava filter * Medical history of any of the following: anticoagulation treatment for pulmonary embolism (within the last six months or ongoing), insulin dependent diabetes, chronic obstructive pulmonary disease, renal dysfunction requiring dialysis, leg amputation, bleeding diathesis, untreated or unresolved systemic infection or local infection, active malignancy except non-melanoma skin cancer, other acute or chronic medical condition that may cause noncompliance with the protocol or confound the study results, documented history of significant untreated stenosis within the arterial system * Positive coronavirus (COVID-19) test six days prior to implant procedure Anatomical: * Inability to clearly visualize target implantation site * Tortuous target implantation site * Inadequate inflow and/or outflow to the target region Procedural: * Inability to gain access to the access site vein * Untreated focal or diffuse stenosis

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic venous insufficiency are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Angiosur S.A.S.

    Antioquia, Colombia

  • Clínica de La Costa S.A.S.

    Barranquilla, Colombia

  • Fundacion Oftalmologica De Santander

    Santander, Colombia

More trials for these conditions

Other studies related to the condition(s) this trial covers.